Plus Medica
Plus Medica is a German medical technology company that develops, sources, and distributes interventional devices for arterial and venous vascular disease treatment, selling a multi-category portfolio including thrombectomy catheters, stents, balloons, and embolization products to hospitals and vascular centers across Europe and select international markets.
- Company typePrivate
- Founded2013
- HeadquartersDüsseldorf, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Plus Medica does
Plus Medica GmbH & Co. KG is a privately held German medical technology company founded in 2013 and headquartered in Düsseldorf, specializing in devices for the treatment of arterial and venous vascular diseases. The company markets a multi-category interventional portfolio — anchored by the BYCROSS rotational thrombectomy/atherectomy catheter (CE Mark since 2021, MDR certified 2024), the blueflow braided nitinol venous stent, carotid and arterial stents (CGuard, InnoSpring, Micro Stent), drug-coated and standard balloons (ELUTAX 3, DKutting series), neuroradiology products (Glutton aspiration catheter, Dredger revascularization device), embolization systems (LAVA liquid embolic, Proender, Carnelian), DuraSheath introducers, DiscoGel orthopedic gel, and the Amica RF/microwave ablation system — serving interventional radiologists, vascular surgeons, and angiology departments in hospitals and specialized vascular centers.
The business operates as a hybrid innovator and specialty distributor: it co-develops and sources devices from technology partners (Taryag Medical in Israel for BYCROSS, HS AMICA for ablation, Heraeus for sheath manufacturing) and holds exclusive German distribution rights for third-party products such as Concept Medical's MagicTOUCH sirolimus drug-eluting balloon and Balton's Jaguar stent. Revenue is generated primarily through one-time device sales to enterprise hospital customers, with pricing that is quote-based and not publicly disclosed. Plus Medica commercializes through a direct field-sales force covering five German regions, four wholly-owned sister companies in Austria, Switzerland, Sweden, and the Netherlands, and distributor partners in Israel, Italy, Spain, Norway, Bulgaria, Brazil, Argentina, Turkey, and the MENA region.
Plus Medica firmographics
Firmographics- Name
- Plus Medica
- Legal name
- plus medica GmbH & Co. KG
- Website
- https://plusmedica.de
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Plus Medica is a German medical technology company that develops, sources, and distributes interventional devices for arterial and venous vascular disease treatment, selling a multi-category portfolio including thrombectomy catheters, stents, balloons, and embolization products to hospitals and vascular centers across Europe and select international markets.
- Ownership category
- akta.pro rank
Plus Medica industry classification
Industry- Product category
- Vascular Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
- akta.pro secondary industry
- Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)
Keywords
Where Plus Medica is headquartered
LocationHeadquarters
- HQ city
- Düsseldorf
- HQ country
- Germany
- HQ region
- Europe
Offices5 records
Markets served
Plus Medica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Revenue model
- Medical Device Sales: Sale of medical devices for vascular disease treatment including stents, catheters, balloons, ablation systems, and related products to hospitals and healthcare facilities.
- Exclusive Distribution: Exclusive distribution rights for third-party products in Germany, including Concept Medical's Sirolimus DEB MagicTOUCH, Micro Medical Solutions MicroStent, and Balton's Jaguar Stent.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Plus Medica product offering
Product offeringCore offering
Plus Medica develops, distributes, and sells a portfolio of medical devices for the treatment of arterial and venous vascular diseases. The company markets interventional vascular products including rotational thrombectomy/atherectomy catheters (BYCROSS), venous and arterial stents, drug-coated balloons, embolic protection and embolization systems, stroke revascularization devices, introducer sheaths, and thermal ablation systems. These devices are sold directly to hospitals and specialized healthcare centers in Germany, Austria, Switzerland, Sweden, the Netherlands, and through international distributor partners.
Product overview
Plus Medica is a Med Tech company specializing in medical devices for the treatment of vascular diseases. The company operates as a distributor and innovator, marketing a portfolio of interventional vascular products across multiple categories: (1) Thrombectomy/Atherectomy devices including BYCROSS rotational catheter; (2) Venous and arterial stents including blueflow Venous Stent, CGuard, InnoSpring, and Micro Stent; (3) Drug-coated and standard arterial balloons including ELUTAX "3" and DKutting series; (4) Neuroradiology products including Glutton aspiration catheter and Dredger revascularization device; (5) Embolization products including LAVA liquid embolic system, Proender embolic protection, and Carnelian microcatheter; (6) Procedural accessories including DuraSheath introducer sheaths; (7) Orthopedic products including DiscoGel; and (8) Thermal ablation systems including Amica (RF/MW). These products are distributed to hospitals and specialized healthcare centers primarily in Germany, Austria, Switzerland, Netherlands, Sweden, and internationally through partner networks.
Differentiator
Problem solved
Functional benefit
Brands
- BYCROSS: Rotational thrombectomy and atherectomy catheter for treatment of peripheral arterial disease
- blueflow Venous Stent
- CGuard
- InnoSpring
- Micro Stent
- DKutting
- ELUTAX 3
- Glutton
- Dredger
- Carnelian
- Proender
- LAVA
- DuraSheath
- DiscoGel
- Amica
Products and services
- BYCROSS 6F bi-directional rotational atherectomy catheter with expandable tip and integrated aspiration pump for treatment of peripheral arterial disease; can be used without wire guidance in some cases and achieved 95.12% acute procedural success in multicenter study.
- blueflow Venous Stent Braided nitinol venous stent designed for below-the-inguinal-ligament application for chronic iliofemoral venous disease treatment; demonstrated 86.7% 1-year primary patency versus 67.3% for laser-cut stents.
- CGuard Carotid stent with integrated embolic protection for stroke prevention during carotid artery interventions and stenting procedures.
- InnoSpring Peripheral interwoven nitinol stent system for arterial applications in peripheral vascular interventions.
- Micro Stent Micro-sized arterial stent for peripheral vascular interventions.
- DKutting Arterial balloon catheter for peripheral interventions.
- DKutting LL Long-length arterial balloon catheter variant for peripheral interventions.
- DKutting XL Extra-large arterial balloon catheter for expanded peripheral intervention applications.
- ELUTAX "3" Third-generation drug-coated balloon with long-term drug release for peripheral arterial disease treatment featuring sustained drug persistence at the lesion site.
- Glutton Aspiration catheter for revascularization in acute ischemic stroke; hybrid coil and braiding structure provides flexibility and maneuverability for intracranial clot removal with larger inner-diameter lumen.
- Dredger Revascularization device with proprietary moving cell design for treatment of acute ischemic stroke due to large vessel occlusion; dual stent-based technology with protective umbrella basket.
- Carnelian Microcatheter for peripheral embolization featuring tungsten braid for kink resistance, PTFE inner coating, and hydrophilic coating for smooth advancement.
- Proender Disposable embolic protection device with soft braided nitinol filter for containment and removal of embolic material during carotid angioplasty and stenting procedures.
- LAVA Non-adhesive, non-absorbable liquid embolic system for embolization of peripheral and neurovascular lesions including AVMs and hypervascular tumors; uses EVOH copolymer dissolved in DMSO with micronized tantalum for radiopacity.
- DuraSheath Percutaneous introducer sheath with wire reinforcement for expanded inner diameter while maintaining reduced outer diameter; features low-friction handling, high stability, and hydrophobic coating.
- DiscoGel Gelled alcohol treatment for intervertebral disc problems; injected with millimeter precision via thin cannula under CT or image converter control, with 80-90% success rate.
- Amica 2-in-1 ablation system combining radiofrequency and microwave technologies in a single generator for thermal ablation of neoplastic or hyperplastic nodules in liver, kidney, lung, bone, and thyroid.
- Embosoft Microparticle embolic product for vascular embolization procedures.
Quantifiable outcome
- 95.12% acute procedural success rate in BYCROSS multicenter study (39/41 lesions)
- +3 more outcomes
Companies that use Plus Medica
Customer profileNamed customers11 records
Segments3 records
Ideal customer profiles2 records
Plus Medica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
Plus Medica partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Taryag Medical Ltd.coreIsraeli partner company and manufacturer of BYCROSS rotational thrombectomy/atherectomy catheter. BYCROSS received CE Mark approval in January 2021 and MDR certification in 2024. Plus medica serves as exclusive distributor for BYCROSS in multiple regions including Germany and Europe.
- Concept MedicalcorePlus medica is official and exclusive distributor for Concept Medical and its Sirolimus DEB MagicTOUCH and Micro Medical Solutions MicroStent in Germany. MagicTOUCH is a drug-eluting balloon technology.
- BaltoncorePlus medica added the Jaguar Stent, a nitinol woven arterial stent, from Balton to their product portfolio in Germany.
- 1a medical agminorSwiss kooperationspartner (cooperation partner) alongside plus medica ag for medical device distribution in Switzerland.
- ADYTON | Full-Service Healthcare DistributorminorFull-service healthcare distributor providing continuous support in advancing BYCROSS, recognized for collaboration with Dr. Samuel Hadvig.
- AngiocareminorNetherlands partner responsible for first BYCROSS cases in Groningen at UMCG with Job Oldenziel and Jean-Paul de Vries.
- ab medica spaminorItalian distributor that helped set up first BYCROSS case in Italy at Peschiera del Garda with Dr. Bruno Migliara.
- TECMEDIC COMÉRCIO PRODUTOS MÉDICOSminorBrazilian distributor for BYCROSS following ANVISA approval for commercial use in Brazil in July 2024.
- Medical World S.A.minorArgentine distributor that accompanied first blueflow Venous Stent insertion in Latin America at Zabala Clinic in Buenos Aires.
- BioArt MedicalminorTurkish distributor (Murat Celebi) that accompanied first blueflow venous stent insertion in Turkey at Altunizade Acibadem Hospital.
- Heartbeat Medical Supplies LLCminorMENA region distributor for first two BYCROSS cases at SEHA Sheikh Khalifa Medical City with Dr. Ottorino Del Foco and Dr. Sharath Paravastu.
- InnoVasc Integral Solutions, S.L.coreSpanish partner company mentioned in context of BYCROSS device development alongside plus medica and Taryag Medical.
- HS AMICAcoreManufacturer of Amica RF/Microwave ablation system. Plus medica distributes Amica products for thermal ablation treatment of neoplastic or hyperplastic nodules.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
Plus Medica competitors and assessment
Company assessmentDirect peers
- Penumbra: Penumbra is a direct competitor in neurovascular aspiration catheters (its Penumbra System competes with Plus Medica's Glutton and Dredger for acute ischemic stroke revascularization), and also sells peripheral thrombectomy devices overlapping with BYCROSS.
- Inari Medical: Inari Medical is a direct competitor in venous and arterial thrombectomy (FlowTriever, ClotTriever, LimFlow), overlapping directly with Plus Medica's BYCROSS rotational atherectomy/thrombectomy catheter for peripheral and venous interventions.
- Concept Medical: Concept Medical manufactures the MagicTOUCH sirolimus drug-eluting balloon and MicroStent that Plus Medica exclusively distributes in Germany, while also selling globally — making Concept Medical both a partner and a product peer in DEB technology.
- Silk Road Medical: Silk Road Medical pioneered TCAR for carotid artery stenting with its embolic protection device, overlapping with Plus Medica's distribution of the CGuard carotid stent system and Proender embolic protection.
- Balton: Balton manufactures the Jaguar nitinol woven arterial stent that Plus Medica distributes in Germany, while also selling stents and catheters directly in other markets — making Balton both a partner and a peer in arterial stenting.
- InspireMD: InspireMD developed the CGuard carotid stent with integrated embolic protection, distributed by Plus Medica — directly comparable as a carotid stenting peer and partnership counterparty.
Broad incumbents
- AngioDynamics: AngioDynamics is a broader incumbent in vascular interventions including thrombectomy (AlphaVac), venous stenting, and embolization — overlapping with multiple categories in Plus Medica's portfolio (thrombectomy, venous stents, embolization products).
- Boston Scientific: Boston Scientific is a broad incumbent with a deep portfolio across peripheral intervention (drug-coated balloons, atherectomy, stents), neurovascular, and venous disease — overlapping with most of Plus Medica's portfolio as a much larger competitor.
- Medtronic: Medtronic is a broad incumbent across vascular surgery, peripheral intervention (IN.PACT drug-coated balloons, HawkOne atherectomy), and neurovascular — directly overlapping with Plus Medica's product categories as a much larger competitor.
- MicroPort Scientific: MicroPort has a broad peripheral and cardiovascular portfolio including drug-eluting stents and balloons, overlapping with Plus Medica's drug-coated balloons (ELUTAX 3), arterial stents, and broader vascular intervention offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Plus Medica social profiles
Digital presencePlus Medica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Plus Medica leadership team
Management profileNumber of profiles
Profiles12 records
Plus Medica subsidiaries and ownership
Company hierarchySubsidiaries5 records
Plus Medica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Plus Medica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Plus Medica
What does Plus Medica do?
Plus Medica develops, distributes, and sells a portfolio of medical devices for the treatment of arterial and venous vascular diseases. The company markets interventional vascular products including rotational thrombectomy/atherectomy catheters (BYCROSS), venous and arterial stents, drug-coated balloons, embolic protection and embolization systems, stroke revascularization devices, introducer sheaths, and thermal ablation systems. These devices are sold directly to hospitals and specialized healthcare centers in Germany, Austria, Switzerland, Sweden, the Netherlands, and through international distributor partners.
Is Plus Medica a public or private company?
Plus Medica is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Plus Medica founded?
Plus Medica was founded in 2013. It employs 1 to 10 people.
Where is Plus Medica based?
Plus Medica is headquartered in Düsseldorf, Germany, in the Europe region.
How does Plus Medica make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are exclusive Distribution.
Who are Plus Medica's main competitors?
Direct peers on record are Penumbra, Inari Medical, Concept Medical, Silk Road Medical, Balton and InspireMD. Broad incumbents are AngioDynamics, Boston Scientific, Medtronic and MicroPort Scientific.
Does Plus Medica have an API?
No public API is recorded for Plus Medica.
What industry is Plus Medica in?
Plus Medica's product category is Vascular Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAKABAG, Vascular Medicine (Peripheral Arterial/Venous Disease). Its NAICS code is 339112 and its SIC code is 3841.